Five Prime Therapeutics Inc (NASDAQ:FPRX)

17.68
Delayed Data
As of Feb 21
 -1.21 / -6.41%
Today’s Change
17.05
Today|||52-Week Range
49.30
-19.34%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 57.25, with a high estimate of 94.00 and a low estimate of 50.00. The median estimate represents a +223.81% increase from the last price of 17.68.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.23
Sales
$14.4M
Reporting Date
Mar 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 20.24%
 
 
 
 
 
 
Growthannually -127.55%
 
 
 
 
 
 

Sales

Growthquarterly 72.37%
 
 
 
 
 
 
Growthannually 32.61%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.